THE DEGRADATION OF CARBOPLATIN IN AQUEOUS-SOLUTIONS CONTAINING CHLORIDE OR OTHER SELECTED NUCLEOPHILES

被引:36
作者
ALLSOPP, MA
SEWELL, GJ
ROWLAND, CG
RILEY, CM
SCHOWEN, RL
机构
[1] UNIV EXETER,POSTGRAD MED SCH,BARRACK RD,EXETER EX2 5DW,ENGLAND
[2] UNIV KANSAS,DEPT PHARMACEUT CHEM,LAWRENCE,KS 66045
[3] UNIV KANSAS,DEPT CHEM,LAWRENCE,KS 66045
关键词
PLATINUM(II) COMPLEX; CARBOPLATIN; CISPLATIN; DEGRADATION; KINETICS; REACTION MECHANISM; PH EFFECT; CHLORIDE EFFECT; TEMPERATURE EFFECT; NUCLEOPHILIC SUBSTITUTION;
D O I
10.1016/0378-5173(91)90362-R
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The degradation kinetics of carboplatin in aqueous solution in the presence and absence of chloride ions were studied at elevated temperatures (43-70-degrees-C) at pH 7.0 and at various pH values at 70-degrees-C. Reaction rates were then extrapolated to temperatures of interest (infusion storage temperature, 'in-use' infusion temperature and body temperature) from Arrhenius plots. Additionally, the effects of pH and added chloride, thiosulphate, thiocyanate, azide and iodide on the rate of degradation of carboplatin were determined in an attempt to obtain a greater insight into the mechanism of nucleophilic substitution of carboplatin.
引用
收藏
页码:197 / 210
页数:14
相关论文
共 11 条
[1]   NUCLEOPHILIC CONSTANTS AND SUBSTRATE DISCRIMINATION FACTORS FOR SUBSTITUTION REACTIONS OF PLATINUM(2) COMPLEXES [J].
BELLUCO, U ;
CATTALIN.L ;
BASOLO, F ;
PEARSON, RG ;
TURCO, A .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1965, 87 (02) :241-&
[2]   EARLY CLINICAL-STUDIES WITH CIS-DIAMMINE-1,1-CYCLOBUTANE DICARBOXYLATE PLATINUM-II [J].
CALVERT, AH ;
HARLAND, SJ ;
NEWELL, DR ;
SIDDIK, ZH ;
JONES, AC ;
MCELWAIN, TJ ;
RAJU, S ;
WILTSHAW, E ;
SMITH, IE ;
BAKER, JM ;
PECKHAM, MJ ;
HARRAP, KR .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 9 (03) :140-147
[3]   STABILITY OF CISPLATIN, IPROPLATIN, CARBOPLATIN, AND TETRAPLATIN IN COMMONLY USED INTRAVENOUS SOLUTIONS [J].
CHEUNG, YW ;
CRADOCK, JC ;
VISHNUVAJJALA, BR ;
FLORA, KP .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1987, 44 (01) :124-130
[4]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC PROCEDURES FOR THE ANALYSIS OF CARBOPLATIN IN HUMAN-PLASMA AND URINE [J].
GAVER, RC ;
DEEB, G .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1986, 16 (03) :201-206
[5]  
HARLAND SJ, 1984, CANCER RES, V44, P1693
[6]  
Harrap K.R., 1980, CISPLATIN CURRENT ST, P193, DOI 10.1016/B978-0-12-565050-2.50016-4
[7]   CLINICAL PHARMACOKINETICS OF CARBOPLATIN [J].
OGURI, S ;
SAKAKIBARA, T ;
MASE, H ;
SHIMIZU, T ;
ISHIKAWA, K ;
KIMURA, K ;
SMYTH, RD .
JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 28 (03) :208-215
[8]  
PENTA JS, 1983, CANCER CHEMOTHERAPY, V1, P149
[9]   REACTIVITY OF CIS DICHLORODIAMMINEPLATINUM(II) (CISPLATIN) TOWARD SELECTED NUCLEOPHILES [J].
RILEY, CM ;
STERNSON, LA ;
REPTA, AJ ;
SLYTER, SA .
POLYHEDRON, 1982, 1 (02) :201-202
[10]   THE STABILITY OF CARBOPLATIN IN AMBULATORY CONTINUOUS INFUSION REGIMES [J].
SEWELL, GJ ;
RILEY, CM ;
ROWLAND, CG .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1987, 12 (06) :427-432